Comparison of the effectiveness of Transdiagnostic treatment and Cognitive-behavioral therapy on Generalized anxiety disorder

Comparison of the effectiveness of Transdiagnostic treatment and Cognitive-behavioral therapy on Emotional regulation, Depressive symptoms, Anxiety and Social adjustment of adolescents with Generalized anxiety disorder

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220502054728N1

Enrollment

Registered

2022-09-13

Start date

2022-09-23

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized anxiety disorder. Generalized anxiety disorder

Interventions

Intervention 1: Intervention group: transdiagnostic treatment: In the present study, twelve 60-70 minute sessions (two sessions per week) of transdiagnostic treatment, according to the standard protoc

translation: Akbari, Cheiniforoshan and Abedi, 2015), will be used in the form of group counseling sessions.

Eligibility

Sex/Gender

All

Age

15 Years to 18 Years

Inclusion criteria

Inclusion criteria: All adolescent referring to Khorram Abad counseling centers Fulfilling all diagnostic criteria of generalized anxiety disorder based on the SCID-5 Providing written informed consent for participation in the study by participants and their parents No presence of any other mental disorders No history of mental illness No dependence on alcohol or drugs Do not receive other current psychological treatment

Exclusion criteria

Exclusion criteria: Having suicidal thoughts and beliefs Diagnosis of other mental disorders Declining to participate in therapy sessions

Design outcomes

Primary

Measure	Time frame
Emotion regulation: the score obtained by the Cognitive Regulation of Emotion Questionnaire (CERQ) (Garnefsky and Kraij, 2006). Timepoint: One week before the intervention, one week after the last intervention session, three month after the last intervention session. Method of measurement: Questionnaire.;Depression: the score obtained by the subjects of the sample group in the depression sub-scale of the depression, anxiety, and stress scale (DASS-21) (Lavibond and Lavibond, 1995). Timepoint: One week before the intervention, one week after the last intervention session, three month after the last intervention session. Method of measurement: Questionnaire.;Anxiety: the score obtained by the subjects of the sample group in the anxiety sub-scale of the depression, anxiety, and stress scale (DASS-21) (Lavi Band and Lavi Band, 1995). Timepoint: One week before the intervention, one week after the last intervention session, three month after the last intervention session. Method of measurement: Questionnaire.;Social adjustment: the score obtained by the subjects of the sample group in the social adjustment sub-scale of the student adjustment questionnaire (Sinha and Singh, 1993). Timepoint: One week before the intervention, one week after the last intervention session, three month after the last intervention session. Method of measurement: Questionnaire.	—

Measure

Time frame

Emotion regulation: the score obtained by the Cognitive Regulation of Emotion Questionnaire (CERQ) (Garnefsky and Kraij, 2006). Timepoint: One week before the intervention, one week after the last intervention session, three month after the last intervention session. Method of measurement: Questionnaire.;Depression: the score obtained by the subjects of the sample group in the depression sub-scale of the depression, anxiety, and stress scale (DASS-21) (Lavibond and Lavibond, 1995). Timepoint: One week before the intervention, one week after the last intervention session, three month after the last intervention session. Method of measurement: Questionnaire.;Anxiety: the score obtained by the subjects of the sample group in the anxiety sub-scale of the depression, anxiety, and stress scale (DASS-21) (Lavi Band and Lavi Band, 1995). Timepoint: One week before the intervention, one week after the last intervention session, three month after the last intervention session. Method of measurement: Questionnaire.;Social adjustment: the score obtained by the subjects of the sample group in the social adjustment sub-scale of the student adjustment questionnaire (Sinha and Singh, 1993). Timepoint: One week before the intervention, one week after the last intervention session, three month after the last intervention session. Method of measurement: Questionnaire.

—

Secondary

Measure	Time frame
Transdiagnostic Treatment: Including twelve 60-70 minute sessions (two sessions per week) of transdiagnostic treatment, according to the standard protocol of transdiagnostic treatment for generalized anxiety disorder, in the form of group counseling sessions. Timepoint: In each treatment session. Method of measurement: Behavior.;Cognitive-behavioral therapy: Including 60-70 minute sessions (two sessions per week) of cognitive-behavioral therapy, according to the standard protocol of cognitive-behavioral therapy for generalized anxiety disorder, in the form of group counseling sessions. Timepoint: In each treatment session. Method of measurement: Behavior.	—

Measure

Time frame

Transdiagnostic Treatment: Including twelve 60-70 minute sessions (two sessions per week) of transdiagnostic treatment, according to the standard protocol of transdiagnostic treatment for generalized anxiety disorder, in the form of group counseling sessions. Timepoint: In each treatment session. Method of measurement: Behavior.;Cognitive-behavioral therapy: Including 60-70 minute sessions (two sessions per week) of cognitive-behavioral therapy, according to the standard protocol of cognitive-behavioral therapy for generalized anxiety disorder, in the form of group counseling sessions. Timepoint: In each treatment session. Method of measurement: Behavior.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahmoud Reza Sharfi

Islamic Azad University

sharafipsychology@gmail+98 66 3343 2180

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026